TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT00540839

A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)

Cause of deathRegulatory or ethics Automatic label, confidence 0.9, unverified. How labels are made.
“Based on input from regulatory agencies, it is not necessary to conduct this study. An ongoing study was sufficient for regulatory purposes.”

The sponsor’s own words in the registry.

Life of this trial

20082010201220142016201820202022Registered2007-10-04Planned start2007-11 (planned)Withdrawn (as of)2022-02-14

Vital statistics

Status
Withdrawn
Phase
Phase 3
Sponsor
Organon and Co
Sponsor type
Industry
Conditions
Asthma, Bronchial
Interventions
Montelukast sodium; Placebo to montelukast; Fluticasone propionate; Placebo to fluticasone
Participants
0

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.